Objective To evaluate the clinical efficacy and safety of ritonavir-boosted danoprevir (DNVr) combined with daclatasvir (DCV) in the treatment of patients with genotype 1b chronic hepatitis C (CHC).Methods Thirty-three patients with genotype 1b CHC admitted in the Department of Infectious Diseases of the First Affiliated Hospital of Nanchang University from August 2018 to February 2019 were enrolled.All the patients received DNVr +DCV antiviral treatment.HCV RNA levels were detected before and 2, 4, 12 weeks after treatment, and after drug withdrawal , respectively.Indicators of liver and kidney function and adverse events were observed.ANOVAV of repeated measurement was used to analyze the data. Results The baseline viral loads of 33 patients ranged from 1.12×104 to 1.76×107 IU／mL.Two weeks after treatment the viral loads of all patients were down to the lowest limit of detection (＜500 IU／mL). Serum ALT, AST and TBil levels returned to norml ( F＝58.26, 14.49 and 20.16, all P＜0.05) and sustained virologic response reached 100%12 weeks after drug withdrawal.Three cases had minor adverse reactions during the treatment.Conclusion DNVr combined with DCV can achieve a rapid and strong virological response in the treatment of patients with genotype 1b CHC with good safety.

Objective To evaluate the antibiotic resistance profile of the Aeromonas strains isolated from extra-intestinal specimens during 7-year period in a tertiary hospital in Chongqing for appropriate antibiotic treatment.Methods WHONET 5.6 software was used to analyze the clinical data and results of antimicrobial susceptibility testing of Aeromonas strains to 14 antibiotics according to CLSI breakpoints (CLSI-M45-A3).Results A total of 230 non-duplicate Aeromonas strains were collected from January 2010 to December 2016.The most common species were Aeromonas hydrophila (83.0％) and Aeromonas sobria (14.8％).Majority of the strains were isolated from wound secretion,bile and urine.Overall,46.8％ of the Aeromonas isolates were resistant to trimethoprim-sulfamethoxazole,followed by ceftriaxone (37.0％) and cefuroxime (28.8％).More than 10％ of the strains were resistant to aztreonam,cefepime and ciprofloxacin.More than 90％ of the strains were susceptible to piperacillin-tazobactam,cefoxitin,levofloxacin,gentamicin,amikacin,imipenem and meropenem.Only 4.0％ and 1.7％ of the strains were resistant to imipenem and meropenem,respectively.Aeromonas hydrophila showed higher antibiotic resistance than Aeromonas sobria to all the antibiotics tested except piperacillin-tazobactam,imipenem,and amikacin.None of the Aeromonas sobria isolates was found resistant to meropenem.Conclusions The Aeromonas hydrophila and Aeromonas sobria isolates are the dominant Aeromonas species in Chongqing.The antibiotic resistant profiles vary with Aeromonas species and site of infection.The use of third generation cephalosporins and trimethoprim-sulfamethoxazole should be cautious in Aeromonas infection due to the high resistance level.